DHR vs VRTV: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and Veritiv Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-23.
Danaher Corporation · Healthcare
$221.12
+29.6% upside to fair value
Med Conviction
Grade B
High Quality
VS
Veritiv Corporation · Industrials
$169.99
-45.0% upside to fair value
Med Conviction
Grade D
QuantHub Verdict
DHR has more upside to fair value
(+29.6%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
VRTV |
| Current Price |
$221.12 |
$169.99 |
| Fair Value Estimate |
$286.52 |
$93.49 |
| Upside to Fair Value |
+29.6%
|
-45.0%
|
| Market Cap |
$155.4B |
$2.3B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
24.8x
|
5.4x
|
| Price / Sales |
6.2x
|
0.4x
|
| Price / FCF |
28.5x
|
10.4x
|
| Revenue Growth YoY |
+5.5%
|
-19.0%
|
| Gross Margin |
58.5%
|
22.7%
|
| Operating Margin |
20.4%
|
5.9%
|
| Return on Equity |
7.7%
|
48.6%
|
| Dividend Yield |
0.65% |
1.48% |
| FCF Yield |
3.51%
|
9.57%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
Danaher is a diversified life-sciences and diagnostics platform spanning three segments: Life Sciences (mass spectrometers, flow cytometry, genomics, bioprocess technologies), Diagnostics (chemistry, immunoassay, microbiology, hematology, molecular and pathology systems), and Environmental & Applied Solutions (water quality and product-identification instrumentation). The business quality is high…
Veritiv Corporation is a business-to-business distributor of specialty packaging, facility solutions, print, and publishing products, operating through four segments with a network of distribution centers and roughly 5,000 employees. The business quality is mixed: it generates a strong 48.6% ROE and trades at a low 7.13 trailing P/E and 5.44 EV/EBITDA, but revenue declined 19.0% year over year in…
Accumulation Zones
| Metric |
DHR |
VRTV |
| Zone Low |
$214.89 |
$70.12 |
| Zone High |
$243.54 |
$79.47 |
| In Buy Zone? |
Yes
|
No
|